A recent study analysed advanced NSCLC biopsies obtained at different TKI treatment time points and found that regulatory T cells and CD8+ T cells expressing PD-1 were enriched at the PD time point [38]. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.